North America Cardiac Biomarkers Testing Market By Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others), By Location of Testing (Point of Care Testing and Laboratory Testing)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiac Biomarkers Testing Market, by Type
1.4.2 North America Cardiac Biomarkers Testing Market, by Application
1.4.3 North America Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 North America Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
Chapter 3. North America Cardiac Biomarkers Testing Market by Type
3.1.1 North America Creatine Kinase (CK-MB) Market by Country
3.1.2 North America Troponins Market by Country
3.1.3 North America Myoglobin Market by Country
3.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 North America Ischemia Modified Albumin Market by Country
3.1.6 North America Others Market by Country
Chapter 4. North America Cardiac Biomarkers Testing Market by Application
4.1.1 North America Myocardial Infarction Market by Country
4.1.2 North America Congestive Heart Failure Market by Country
4.1.3 North America Acute Coronary Syndrome Market by Country
4.1.4 North America Atherosclerosis Market by Country
4.1.5 North America Others Market by Country
Chapter 5. North America Cardiac Biomarkers Testing Market by Location of Testing
5.1.1 North America Point of Care Testing Market by Country
5.1.2 North America Laboratory Testing Market by Country
Chapter 6. North America Cardiac Biomarkers Testing Market by Country
6.1 USA Cardiac Biomarkers Testing Market
6.1.1 USA Cardiac Biomarkers Testing Market by Type
6.1.2 USA Cardiac Biomarkers Testing Market by Application
6.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
6.2 Canada Cardiac Biomarkers Testing Market
6.2.1 Canada Cardiac Biomarkers Testing Market by Type
6.2.2 Canada Cardiac Biomarkers Testing Market by Application
6.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
6.3 Mexico Cardiac Biomarkers Testing Market
6.3.1 Mexico Cardiac Biomarkers Testing Market by Type
6.3.2 Mexico Cardiac Biomarkers Testing Market by Application
6.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
6.4 Rest of North America Cardiac Biomarkers Testing Market
6.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
6.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
6.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses